Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Dismenorea menimbulkan dampak langsung yang cukup luas baik bagi penderita, keluarga, masyarakat ataupun negara dan bangsa. Masalah yang timbul dikaitkan dengan peningkatan angka absensi sekolah dan pekerjaan, yang berakibat pada penurunan produktivitas dan pada gilirannya akan mempengaruhi perekonomian negara dan bangsa. Pada studi yang pernah dilakukan oleh Park, pada suatu sekolah, menunjukkan 42% siswi harus absen atau tidak dapat beraktivitas karena keluhan dismenorea. Sementara dari penelitian lain yang pernah dilakukan oleh Andersch diteniukan angka absensi antara 34 sampai 50% pada perempuan yang mengalami dismenorea. Dari segi perekonomian Dawood mengemukakan bahwa di Amerika Serikat hampir 600 juta jam kerja yang setara dengan nilai 2 miliar dollar hilang setiap tahunnya akibat dismenorea yang terjadi pada perempuan usia reproduksi. Kerugian yang timbul juga berhubungan dengan jumlah biaya yang dibutuhkan untuk membeli obat dalam mengatasi gejala dismenorea yang timbal. Karena demikian luasnya dampak yang dapat ditimbulkan oleh dismenorea, maka penatalaksanaan yang tepat untuk mengatasi keluhan yang ada sangatlah diperlukan. Penatalaksanaan dismenorea yang dikemukakan pada berbagai kepustakaan meliputi penatalaksanaan non operatif dan operatif. Penatalaksanaan non operatif dapat berupa pemberian obat-obatan anti prostaglandin, kontrasepsi hormonal oral, antagonis kalsium, perangsang adrenoseptor beta, sediaan hormonal, asam lemak Omega 3, vitamin Bl, Magnesium. AIternatif lain yang pernah dikemukakan adalah dengan akupunktur dan transcutaneous electric nerve stimulation (TENS). Sedangkan terapi operatif dapat berupa dilatasi dan kuretase, laparoscopic uterine nerve ablation (LUNA), neurektomi presakral atau histerektomi total. Laparoscopie Uicrosacral Nerve Ablation (LUNA) merupakan tindakan operatif" dengan melakukan pemotongan persarafan uterus pada ligamentum sakrouterina dekat insersionya pada uterus dengan menggunakan teknik pendekatan laparoskopi. Cara ini saat ini menjadi salah satu alternatif dalam mengatasi dismenorea berat yang tidak respon dengan jenis pengobatan lainnya. Dengan pendekatan laparoskopi dan menggunakan suatu electro surgical system dilakukan pemotongan ligamentum sakrouterina pada insersionya dekat di uterus. Pemotongan ligamentum sakrouterina dapat dilakukan secara total/komplit ataupun parsial. Pada penelitian ini seianjutnya teknik pemotongan ligamentum sakrouterina secara total disebut dengan Ablasi Nervus Sakro Uterina per Laparoskopi (ANUL), sedangkan teknik koagulasi ligamentum sakrouterina secara menyeluruh disebut sebagai Koagulasi Ligamentum Sakro Uterina per Laparoskopi (KoLSU). Meskipun dari laporan penelitian di luar negeri efektifitas dan angka keberhasilannya cukup tinggi, namun di Indonesia belum pemah dilaporkan tingkat efektifitas dan keberhasilannya dalam mengatasi dismenorea berat. Oleh karena itu penelitian inl akan meneliti efektifitas kedua teknik tersebut dalam menurunkan keluhan dismenorea, dan sekaligus membandingkannya pada populasi tertentu oraag Indonesia yang menderita dismenorea berat. RUMUSAN MASALAH Belum diketahui perbedaan efektifitas Ablasi Nervus Sakro Uterina per Laparoskopi (ANUL) dengan Koagulasi Ligamentum Sakro Uterina per Laparoskopi (KoLSU ) dalam mengatasi dismenorea berat. TUJUAN PENELITIAN Tujuan Umum : Menilai dan membandingkan efektifitas ANUL dan KoLSU dalam mengatasi dismenorea berat. Tujuan Khusus: 1. Mengetahul karakteristik demografi dan kiinis penderita dismenorea berat. 2. Menilai patologi organ pelvik secara laparoskopi pada penderita dismenorea berat.

Abstrak :
Latar belakang: Peran estrogen pada patofisiologi endometriosis sudah dikenal sejak lama. Namun, belum ada studi yang menganalisis rasio estradiol, estron dan estriol antara wanita dengan dan tanpa endometriosis. Tujuan: Menganalisis kadar estron (E1), estradiol (E2) dan estriol (E3) dalam darah dan rasio E2:E1, E2:E3 dan E1:E3 antara wanita dengan dan tanpa endometriosis. Metode: Penelitian dengan desain potong lintang analitik, dengan 27 wanita dengan endometriosis dan 27 wanita tanpa endometriosis yang memenuhi kriteria inklusi. Sampel didapatkan dari RS Cipto Mangunkusumo dan rumah sakit jejaring lainnya periode Oktober 2012 - April 2013. Kadar metabolit estrogen dalam darah diperiksa dengan uji enzyme-linked immunosorbent (ELISA). Perbandingan data antara dua kelompok dianalisis dengan uji Mann-Whitney. Hasil: Kadar estron ditemukan lebih rendah pada kelompok endometriosis dibandingkan kelompok kontrol (54,66 pg/ml vs 73,52 pg/ml, p 0,229). Demikian pula, kadar estradiol dan estriol lebih rendah pada kelompok endometriosis (29 pg/ml vs 35 pg/ml, p 0,815 dan 1,11 pg/ml vs 1,67 pg/ml, p 0.095, berturut-turut). Rasio E2:E1 lebih tinggi pada kelompok endometriosis (0,51 pg/ml vs 0,38 pg/ml, p 0,164), demikian pula dengan rasio E2: E3 (26,53 pg/ml vs 21,11 pg/ml , p 0,223) dan rasio E1:E3 (58,55 pg/ml vs 50,28 pg/ml, p 0,684). Namun, semua perbedaan itu tidak bermakna secara statistik. Kesimpulan: Kadar estron, estradiol, dan estriol pada wanita dengan kelompok endometriosis lebih rendah dibandingkan pada wanita tanpa endometriosis. Rasio E2: E1, E2: E3 dan E1: E3 lebih tinggi pada kelompok endometriosis. Namun, semua perbedaan itu tidak bermakna secara statistik.

---

Background: The role of estrogen in the pathophysiology of endometriosis has been well known. However, no study has observed the ratio of estradiol, estrone, and estriol between women with endometriosis and without endometriosis. Objectives: To assess the estrone (E1), estradiol (E2) and estriol (E3) blood level and its ratio (E2:E1, E2:E3 and E1:E3) between women with and without endometriosis. Methods: An analytical cross sectional study with 27 women with endometriosis and 27 women without endometriosis who met the inclusion criteria. The samples were recruited in Cipto Mangunkusumo hospital and other satellite hospitals from October 2012 to April 2013. The blood level of estrogen metabolites was examined by enzyme-linked immunosorbent assay (ELISA). The data comparison between two groups was analyzed by using Mann-Whitney test. Result: The level of Estrone was found to be lower in endometriosis group compared to this in control group (54,66 pg/ml vs 73,52 pg/ml, p 0.229). Similarly, the level of estradiol and estriol were lower in endometriosis group (29 pg/ml vs 35 pg/ml, p 0.815 and 1,11 pg/ml vs 1,67 pg/ml, p 0.095, consecutively). The E2:E1 ratio was higher in endometriosis group (0,51 pg/ml vs 0,38 pg/ml, p 0.164), as well as E2:E3 ratio (26,53 pg/ml vs 21,11 pg/ml, p 0.223) and the E1:E3 ratio (58.55 vs 50.28, p 0.684). However, all those differences were not statistical significant. Conclusion: The estrone, estradiol and estriol level in women with endometriosis group was lower compared to these in women without endometriosis group. The ratio E2:E1, E2:E3 and E1:E3 was higher in endometriosis group. However, all those differences were statistically insignificant.

Abstrak :
Membandingkan dan menentukan rerata kadar AMH serum pada wanita infertil dengan tanpa endometriosis serta mengetahui rerata kadar AMH serum pada masing-masing derajat endometriosis. Metode: Penelitian ini merupakan penelitian potong lintang (cross sectional). Enam puluh delapan subjek yang menjalani laparoskopi, yang masuk dalam kriteria penerimaan dibagi menjadi dua kelompok sama besar, yakni kelompok endometriosis dan tanpa endometriosis secara konsekutif (consecutive sampling). Masing-masing subjek diambil percontoh dari darah sebelum dilakukan laparoskopi kemudian diukur kadar AMH serum. Rerata masing-masing kelompok diuji statistik dengan uji Mann-Whitney. Hasil: Rerata kadar AMH serum pada kelompok endometriosis lebih rendah dibandingkan dengan tanpa endometriosis dan secara statistik berbeda bermakna (2,30+1,8 ng/ml vs 3,75+2,13 ng/ml; p=0,005). Dengan uji Kruskal-Wallis, didapatkan perbedaan bermakna secara statistik pada subjek kelompok endometriosis berdasarkan derajat endometriosis (p=0,005). Bila dilakukan pengelompokkan kelompok endometriosis minimal-ringan dan kelompok endometriosis sedang-berat dibandingkan dengan kelompok tanpa endometriosis, maka hasilnya menunjukkan tidak adanya hubungan yang bermakna antara kadar AMH serum pada kelompok endometriosis minimal-ringan dengan kelompok tanpa endometriosis (p=0,34), sedangkan pada kelompok endometriosis sedang-berat dengan kelompok tanpa endometriosis terdapat hubungan yang bermakna (p<0,005).

---

To compare and to determine the differences in levels of serum AMH in infertile women with and without endometriosis, and also to determine the mean levels of serum AMH in every grade of endometriosis. Methods: This study is a cross-sectional study. Sixty-eight subjects who have undergone laparoscopy fulfilled the inclusion criteria are included and divided into two groups, i.e groups of endometriosis and without endometriosis consecutively (consecutive sampling). Blood samples are taken from each subject before laparoscopy which is then measured the levels of serum AMH. The mean levels of each group are tested with an Mann-Whitney test. Results: The mean levels of serum AMH were lower in the endometriosis group than that group without endometriosis and it was statistically significance ( 2,30+1,8 ng/ml vs 3,75+2,13 ng/ml; p=0,005). With Kruskal-Wallis test, it was found that there was statistically significant difference among endometriosis group based on grading. There was no different at the mean levels of serum AMH between the minimal-mild endometriosis group and without endometriosis group (p=0,34), but the mean levels of serum AMH was lower in the moderate-severe endometriosis compare to the group without endometriosis and it was statistically significance (p<0,005). Conclusions: The mean levels of serum AMH in infertile women with endometriosis were lower than that group without endometriosis and were statistically significantly different. There was no different between the mean levels of serum AMH in minimal-mild endometriosis group and that group without endometriosis, while in moderate-severe endometriosis group, it was lower than without endometriosis and it was statistically significance.

Abstrak :
ABSTRAK
Latar Belakang: Endometriosis merupakan kondisi yang sering ditemukan pada wanita usia reproduksi. Keterlambatan dignosis masih menjadi kendala. Saat ini, metode diagnosis non invasif termasuk transvaginal sonography telah direkomendasikan. Penelitian ini bertujuan mengevaluasi akurasi transvaginal sonogrpahy untuk mendiagnosis kista endometriosis di RS Cipto Mangunkusumo

Metode: Penelitian ini merupakan penelitian uji diagnostik yang dilakukan di RS Cipto Mangunkusumo pada Januari 2014 ? Juni 2015. Subjek penelitian merupakan pasien rawat jalan dengan kecurigaan kista endometriosis berdasarkan anamnesis dan pemeriksaan fisik. Pasien kemudian diperiksa transvaginal sonography oleh pemeriksa berpengalaman sesuai dengan protokol penelitian. Selanjutnya, pemeriksaan histologi dengan sediaan masa yang diambil dari prosedur operasi dijadikan baku emas

Hasil: Terkumpul 98 pasien yang dianalisis. Kista endometriosis terkonfirmasi pada 85 pasien (86,7%) berdasarkan pemeriksaan histologi. Akurasi, sensitivitas, spesifisitas, nilai duga positif dan nilai duga negatif transvaginal sonography yakni 84,9 (71,0-98,8)%, 92,9%, 76,9%, 96,3%, and 62,5%. Transvaginal sonography memiliki area under the curve yang lebih tinggi secara signifikan dibandingkan dengan hanya pemeriksaan fisik (84,9% vs 78,8%).

Kesimpulan: Transvaginal sonogprahy bermanfaat untuk mendiagnosis kista endometriosis dan dapat direkomendasikan dalam praktik sehari-hari

---

ABSTRACT
Background: Endometriosis is common among reproductive age women. Late diagnosis is still the main concern. To date, non-invasive diagnostic test including transvaginal sonography is recommended. This study aimed to evaluate the accuracy of transvaginal sonography to diagnose endometriosis cyst among patients in Cipto Mangunkusumo Hospital.

Method: This was a diagnostic study performed in Cipto Mangunkusumo Hospital from January 2014 to June 2015. Outpatients with suspicion to have endometrial cyst based on patients? history and clinical examination were recruited. Patients were then scanned by experienced sonologist using transvaginal sonography following our research protocol. The gold standard was histologic finding of removed surgical mass

Results: A total of 98 patients were analyzed. Endometrial cyst was confirmed by histology among85 patients (86.7%). The accuracy, sensitivity, specificity, positive predictive value and negative predictive value of transvaginal sonography were 84.9 (71.0-98.8)%, 92.9%, 76.9%, 96.3%, and 62.5%, respectively. Transvaginal sonogpraphy significantly had higher area under the curve compared to clinical examination alone (84.9% vs 78.8%).

Conclusion: Transvaginal sonography appears to be usefull to diagnose endometriosis cyst among outpatients and recommended in daily clincial practice

Abstrak :
Latar Belakang: Karsinoma endometrium adalah keganasan pada organ reproduksi wanita yang terjadi umumnya pada wanita pasca menopase. Pemeriksaan radiologi khususnya MRI merupakan penunjang penting dalam menentukan staging dan keterlibatan organ organ rongga panggulyang akan menentukan pilihan terapi. Perkembangan teknik fungsional MRI yakni diffusion weighted imaging (DWI) dan apparent diffusion coefficient (ADC)digunakan untuk membedakan lesi jinak dengan ganas, grading disertai dengan perluasannya, tetapi sayangnya teknik inimemiliki keterbatasanyakni nilai yang dihasilkan pada setiap alat MRI heterogen. Saat ini berkembang teknik baru yang membandingkan nilai ADC jaringan lesi dengan nilai ADC jaringan sehat dengan hasil nilai yang lebih homogen. Tujuan: Tujuan penelitian ini adalah membuktikan nilai rerata rasio ADC memilikihasil lebih homogen dibandingkan dengan nilai rerata ADC. Metode: Penelitian ini menggunakan desain penelitian deskriptif potong lintang menggunakan data sekunder. Penelitian dilakukan mulai bulan Desember 2018 hingga Maret 2019, dengan jumlah sampel sebanyak 21 sampel. Hasil: Median nilai ADC tumor endometrium, urin, dan miometrium adalah 0,58 mm2/s, 3,26 mm2/s, dan 1,52 mm2/s. Berdasarkan coefficient of variation (COV) nilai rasio ADC lebih homogen dibandingkan dengan nilai ADC tumor (nilairasio ADC tumor-urine 35,1%, tumor-miometrium 41,7%, dan ADC tumor 42,2%). Kesimpulan: Nilai rasio ADC memiliki nilai yang lebih homogen dibandingkan dengan nilai ADC, sehingga dapat digunakan sebagai parameter non-invasif dalam mengevaluasi tumor. ...... Background: Endometrial carcinoma is most common gynecologic malignancy that occurs usually in postmenopausal women. Imaging examination, especially MRI, is important in determining the staging and involvement of intrapelvic organs, which will determine the therapy for the patient. Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) can be used to help distinguish benign or malignant lesions, grading and expansion of the lesion, but unfortunately this technique produced heterogeneous values. Currently a new technique is developing that compares the tissue ADC value of lesions with healthy tissue, resulting more homogeneous values. Purpose: The purpose of this study is to prove the average value of the ADC ratio has more homogeneous results than the average value of the ADC. Methods: This study uses a cross-sectional descriptive design, using secondary data. The study was conducted from December 2018 to March 2019, with a total sample of 21. Result: The median ADC value of endometrial, urine, and myometrial tumors was 0.58 mm2 / s, 3.26 mm2 / s, and 1.52 mm2 / s. Based on coefficient of variation (COV) the ADC ratio value is more homogeneous compared to the tumor ADC value (tumor-urine ADC ratio value is 35.1%, myometrial tumor 41.7%, and tumor ADC 42.2%). Conclusion: The ADC ratio value has a more homogeneous value than the ADC value, so it can be used as a non-invasive parameter in evaluating tumors.

Abstrak :
Pengantar: Endometriosis merupakan salah satu penyebab infertilitas dan menjadi indikasi fertilisasi in vitro (FIV). Laju apoptosis dan stress oksidatif yang tinggi pada pasien endometriosis diyakini menimbulkan efek negatif terhadap peluang keberhasilan FIV. Namun, pengaruh endometriosis terhadap keberhasilan FIV menunjukkan bukti yang inkonsisten dan belum banyak studi yang menilai langsung efek endometriosis terhadap kualitas oosit sebagai parameter keberhasilan FIV. Tujuan: Untuk menilai laju apoptosis pada sel granulosa pasien endometriosis dibanding pasien non-endometriosis melalui rasio ekspresi mRNA BAX/BCL-2 dan menilai korelasinya dengan kualitas oosit yang didapatkan saat petik ovum. Hasil: Sampel didapatkan dari 15 subjek dengan endometriosis dan 15 subjek kontrol. Dosis rekombinan FSH total yang diterima pada kelompok endometriosis untuk stimulasi ovarium lebih tinggi dibandingkan kelompok kontrol (p=0.005). Terdapat perbedaan bermakna kadar ekspresi BAX (p=0.029) dan BCL-2 (p<0.001) pada kedua kelompok, tetapi perbedaan rasio keduanya tidak signifikan (p=0.787). Korelasi antara rasio BAX/BCL-2 dengan parameter kualitas oosit tidak menunjukkan hubungan bermakna di kedua kelompok. Kesimpulan: Tidak terdapat perbedaan signifikan pada rasio kadar BAX/BCL-2 di kedua kelompok dan tidak ditemukan hubungan bermakna antara rasio tersebut dengan kualitas oosit.  ...... Introduction: Endometriosis is one of common conditions causing infertility and an indication to undergo in vitro fertilization (IVF). High apoptosis rate and oxidative stress in patient with endometriosis is believed to cause negative effect on IVF success rate. However, there has been conflicting results on endometriosis effect to IVF success and there have been limited studies that directly assess endometriosis and its effect on oocyte quality. Aim: To assess apoptosis rate on granulosa cells in patients with endometriosis compared to non-endometriosis patients through mRNA BAX/BCL-2 ratio and how it correlates with oocyte quality collected during ovum pick up. Results: Samples were collected from 15 subjects with endometriosis and 15 control subjects. Total dose of recombinant FSH received by endometriosis group is significantly higher compared to control (p=0.005). There is difference in BAX level (p=0.029) and BCL-2 level (p<0.001) in both groups. However, the ratio does not differ significantly (p=0.787). No significant correlation is found in BAX/BCL-2 ratio and any of the oocyte quality parameters. Conclusion: We found no significant difference in BAX/BCL-2 ratio between endometriosis and control group as well as significant correlation between the ratio and oocyte quality.

Abstrak :
ABSTRAK
Latar belakang: Endometriosis merupakan kelainan ginekologik yang paling sering ditemukan. Seperti halnya endometrium di uterus juga dapat terjadi berbagai perubahan pada epitel yang melapisi kista endometriosis di ovarium, antara lain metaplasia, hiperplasia, atipia bahkan perubahan ke arah keganasan. Saat ini banyak penelitian yang menghubungkan antara endometriosis dan kanker ovarium terutama jenis clear cell dan dikenal dengan istilah endometriosisassociated ovarian carcinoma (EAOC) dan dilaporkan adanya mutasi yang menginaktifkan gen supresor tumor (ARID1A), sehingga protein BAF250a tidak diekpresikan pada Clear cell carcinoma (CCC) ovarii. Bahan dan cara: Dilakukan pulasan imunohistokimia ARID1A pada sampel 20 kasus endometriosis non atipik, 20 kasus atipik dan 20 kasus CCC ovarii tahun 2012 hingga Maret 2015. Dari kelompok kasus CCC didapatkan 9 kasus EAOC. Selanjutnya dilihat adakah perbedaan persentase ekspresi ARID1A pada endometriosis non atipik, atipik, CCC ovarii serta endometriosis disertai CCC (EAOC). Hasil: Pada kelompok kasus endometriosis non atipik, atipik dan CCC ada perbedaan bermakna persentase ekspresi ARID1A (uji Kruskal-Wallis p=0,0035). Selanjutnya dilakukan analisis Post Hoc uji Mann-Whitney dan didapatkan perbedaan bermakna persentase ekspresi ARID1A antara endometriosis non atipik dan atipik dengan CCC ovarii (p=0,001 dan p=0,0015). Pada kelompok kasus endometriosis non atipik, atipik dan endometriosis pada EAOC, didapatkan ada perbedaan bermakna persentase ekspresi ARID1A (Uji Kruskal-Walis p=0,011). Selanjutnya dilakukan analisis Post Hoc uji Mann-Whitney dan ada perbedaan bermakna persentase ekspresi ARID1A antara endometriosis non atipik dan atipik dengan EAOC (p=0,005 dan p=0,008). Kesimpulan: Ekspresi ARID1A pada endometriosis non atipik dan atipik lebih tinggi bermakna dibanding CCC ovarii dan EAOC. Sehingga ekspresi ARID1A kemungkinan dapat digunakan sebagai petanda adanya transformasi ganas pada endometriosis. ABSTRACT
Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis. ;Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis. ;Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis. ;Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis.

Abstrak :
Latar Belakang: Kejadian infertilitas di Indonesia 10-15 dari 39,8 juta wanita usia subur. Infertilitas dapat memberi masalah fisik, mental, sosial hingga perceraian. Sekitar 25 -50 perempuan infertil disertai endometriosis dan laparoskopi telah menjadi salah satu pilihan tatalaksananya. Dalam menjalani suatu metode, ahli bedah dan pasangan selalu ingin mengetahui peluang keberhasilan mereka baik dari data praoperasi ataupun intraoperasi. Lee dkk menyatakan keberhasilan kehamilan alamiah pasca laparoskopi secara keseluruhan adalah 41,9 dan tidak berhubungan dengan derajat endometriosis atau temuan laparoskopi atau jenis operasi. Di Indonesia, belum ada studi yang membahas faktor yang paling mempengaruhi keberhasilan kehamilan alamiah pada perempuan yang menjalani metode laparoskopi operatif.Tujuan: Penelitian ini bertujuan untuk mengetahui faktor-faktor apa saja yang mempengaruhi keberhasilan kehamilan alamiah pasca laparoskopi operatif.Metode: Penelitian ini menggunakan desain kohort retrospektif. Dengan total sampling, data diambil dari catatan pasien yang menjalani operasi laparoskopi karena infertilitas dengan endometriosis di RS Cipto Mangunkusumo dan RS Yayasan Pemeliharaan Kesehatan YPK di Jakarta, Indonesia. Analisis data dilakukan dengan perangkat lunak SPSS 20 untuk mengetahui hubungan antara usia, durasi infertilitas, jenis infertilitas, kadar CA-125, ukuran dan bilateralitas endometrioma, perlekatan organ genitalia interna, nodul endometriosis dan patologi tuba dengan keberhasilan kehamilan alamiah dalam 1 tahun pasca laparoskopi operatif.Hasil: Terdapat 70 subjek yang dianalisis. Sebanyak 32 subjek 45,7 hamil dalam satu tahun pasca laparoskopi. Lama infertilitas menggunakan titik potong ......Background and aims The incidence of infertility in Indonesia is 10 15 of the 39.8 million women of childbearing age. It can give physical, mental, social and divorce problems. Approximately 25 50 of infertile women cause by endometriosis. Laparoscopy operative LO has become one of its treatments. In choosing a method, surgeon and couples always want to know the chances of their success either from preoperative or intraoperative data. In Indonesia, there are no studies that address the factors influence the success of natural pregnancy in women undergoing LO methods. This study aims to determine what factors affect the success of natural pregnancy postoperative laparoscopy.Methods This study used a retrospective cohort design. With total sampling, the data were taken from the patient records who underwent laparoscopic operative due to infertility with endometriosis at RS Cipto Mangunkusumo and the Health Care Foundation Foundation YPK in Jakarta, Indonesia. Data analysis was performed with SPSS 20 software to determine the relationship between age, duration of infertility, type of infertility, ca 125 levels, size and bilaterality of endometrioma, internal genital adhesion, endometriosis nodules and tubal pathology with successful natural pregnancy in 1 year after laparoscopic operative.Result There were 70 subjects analyzed. A total of 32 subjects 45.7 were pregnant within one year after laparoscopy. The length of infertility using a

Abstrak :
Latar Belakang: Salah satu hipotesis yang menjelaskan hubungan endometriosis dengan infertilitas adalah endometriosis diyakini menyebabkan gangguan fisiologi ovarium, salah satunya dengan mempengaruhi folikulogenesis yang menyebabkan penurunan kualitas oosit. Oosit memainkan peran penting dalam mengatur dan mendukung pertumbuhan folikel, melalui produksi faktor pertumbuhan oosit. Beberapa faktor pertumbuhan telah diidentifikasi pada oosit manusia, termasuk growth differentiation factor-9 GDF-9 . Namun, sampai saat ini penelitian mengenai ekspresi GDF-9 pada sel granulosa pada wanita infertil dengan endometriosis masih belum banyak dilakukan. Tujuan: Untuk mengetahui ekspresi mRNA GDF-9 pada sel granulosa pasien endometriosis yang menjalani FIV dan untuk mencari adanya korelasi antara ekspresi GDF-9 dengan kualitas oosit. Metode: Penelitian potong lintang ini dilakukan di Klinik IVF Yasmin RSCM dan Klinik Sander B di Jakarta pada bulan Juli 2014 - Juli 2017. Sebanyak 50 sampel terdiri atas 25 wanita dengan endometriosis dan 25 kontrol. Sampel sel granulosa dikumpulkan pada saat petik oosit. Ekspresi mRNA GDF-9 dinilai menggunakan real time PCR. Hasil: Terdapat penurunan jumlah ambilan oosit, jumlah oosit matur dan skor morfologi oosit pada kelompok pasien dengan endometriosis dan bermakna secara statistik. Ekspresi GDF-9 secara kuantitatif lebih rendah pada kelompok endometriosis dibandingkan dengan kontrol 5.05 0.00002 ndash; 3523 ng/ l vs 81.93 1,47 ndash; 32450 ng/ l; p=0,01 . Pada penelitian ini tidak didapatkan korelasi antara ekspresi GDF-9 dan kualitas oosit dari skor morfologi oosit dan laju fertilisasi. Kesimpulan: Ekspresi GDF9 lebih rendah pada kelompok endometriosis dibandingkan kelompok kontrol. Namun, kami tidak menemukan korelasi antara ekspresi GDF-9 dengan kualitas oosit. Dibutuhkan studi dengan besar sampel yang lebih besar untuk mengkonfirmasi apakah perubahan ekspresi GDF-9 memiliki korelasi dengan kualitas oosit serta untuk membuktikan apakah GDF-9 dapat digunakan sebagai penanda molekuler baru untuk memprediksi kompetensi perkembangan oosit.

---

Background: One of the hypothesis that explains the association between endometriosis and infertility is that endometriosis is believed to cause ovarian physiology disturbances, one of them by affecting folliculogenesis that cause decreased oocyte quality. The oocyte plays an important role in regulating and promoting follicle growth, by the production of oocyte growth factors. Several growth factors have been identified in human oocytes, including growth differentiation factor-9 GDF-9. However the studies on GDF-9 expression in granulosa cells of infertile women with endometriosis are sparse. Objective: To investigate the expression of GDF-9 mRNA in granulosa cells of endometriosis patients undergoing IVF and to find the correlation between GDF-9 expression and oocyte quality. Method: This cross sectional study was done at Yasmin IVF Clinic and dr. Sander B Clinic Jakarta in July 2014 - July 2017. A total fifty samples of 25 womens with endometriosis and 25 controls were included. We collect the granulosa cells sample at the time of oocyte retrieval. GDF-9 mRNA expression were investigated by Real-Time PCR. Result: The number of oocytes retrieved, mature oocytes and the oocyte morphology score were lower in the group of patients with endometriosis and this was statistically significant. GDF-9 mRNA expression levels was quantitatively lower in endometriosis groups compared to control 5.05 0.00002 ndash; 3523 ng/ l vs 81.93 1,47 ndash; 32450 ng/ l; p=0,01. However, we did not find any correlation between GDF-9 expression levels and oocyte quality from oocyte morphology score and fertilization rate. Conclusion: GDF9 mRNA level was lower in endometriosis group compared to control group. However, we did not find correlation between individual GDF-9 level and oocyte quality. Large-sample studies were needed to confirm whether the expression of GDF-9 had a correlation with oocyte quality as well as to prove whether GDF-9 could be used as a new molecular marker to predict the oocyte developmental competence.

Abstrak :

Latar belakang: Heterogenitas pasien endometriosis terkait presentasi fenotip klinisnya memerlukan standar pengambilan data. Saat ini belum ada standardisasi pengambilan data fenotip klinis pasien endometriosis di Indonesia. Translasi kuesioner klinis WERF-EPHect Clinical Questionnaire (Standard) (EPQ-S) ke dalam Bahasa Indonesia dan validasi kuesioner ini diperlukan untuk mengetahui apakah alat ini dapat digunakan di Indonesia sebagaimana telah digunakan di negara lain dan memastikan bahwa data yang dihasilkan akurat dan andal.

 

Tujuan: Untuk membuat sebuah standar pengambilan data fenotip klinis pasien endometriosis di Indonesia dan untuk mengetahui hasil terjemahan dan validitas kuesioner klinis WERF-EPHect Clinical Questionnaire (Standard) (EPQ-S) yang telah diterjemahkan ke dalam Bahasa Indonesia

 

Metode: Penelitian ini dilakukan dengan metode transkultural adaptasi. Uji validasi ini kuesioner EPHect EPQ-S dilakukan melalui proses forward-backward translation, harmonisasi oleh para expert, cognitive debriefing kepada target kuesoioner serta proofreading dan finalisasi oleh para expert. Penelitian dilakukan di RSCM selama 6 bulan yaitu Januari 2019 sampai Juli 2019.

 

Hasil: Translasi dan validasi isi kuesioner WERF-EPHect Clinical Questionnaire (Standard) Versi Indonesia memiliki 10 tahap termasuk proses persiapan, Forward Translation (translasi maju), proses rekonsiliasi, Backward Translation (translasi balik), review translasi balik, Proses Harmonisasi, proses Cognitive Debriefing, review hasil cognitive debriefing dan finalisasi, proses Proofreading dan laporan Final. Terdapat perbedaan budaya dari negara kuesioner asal termasuk obat-obatan yang tersedia di Indonesia, istilah-istilah medis yang lumrah di Negara asal namun asing di populasi Indonesia, dan penyajian suku ras yang tidak menggambarkan varian suku ras Indonesia.

 

Kesimpulan: Didapatkan kuesioner klinis WERF-EPHect Clinical Questionnaire (Standard) (EPQ-S) versi Bahasa Indonesia dengan isi sesuai kebutuhan pengguna di Indonesia dan dapat diaplikasikan di RSCM, dari 116 butir pertanyaan terdapat 21 butir pertanyaan dalam kuesioner yang harus terpimpin.

 

---

Background: The heterogeneity of endometriosis patients related to the presentation of clinical phenotypes requires standard data collection. At present there is no standardization of clinical phenotype data for endometriosis patients in Indonesia. Translation of the WERF-EPHect Clinical Questionnaire (Standard) clinical questionnaire (EPQ-S) into Indonesian language and the validation of this questionnaire is needed to find out whether this tool can be used in Indonesia as it has been used in other countries and ensure that the resulting data is accurate and reliable.

 

Objective: To create a standard for taking clinical phenotype data for endometriosis patients in Indonesia and to find out the translation results and the validity of the WERF-EPHect Clinical Questionnaire (Standard) clinical questionnaire (EPQ-S) that has been translated into Indonesian and has been accurate and reliable.

 

Method: This research was conducted with the transcultural adaptation method. This validation test EPHect EPQ-S questionnaire was carried out through a process of forward-backward translation, harmonization by experts, cognitive debriefing to questionnaire targets and proofreading and finalization by experts. The study was conducted at the RSCM for 6 months, namely January 2019 to July 2019.

 

Results: Translation and validation of the contents of the Indonesian version of the WERF-EPHect Clinical Questionnaire (Standard) questionnaire have 10 stages including the preparation process, Forward Translation, forward reconciliation process, Backward Translation, back translational review, Harmonization Process, Cognitive Debriefing process, reviewing cognitive debriefing and finalization results, Proofreading process and Final report. There are cultural differences from the country of origin of the questionnaire including medicines available in Indonesia, medical terms that are common in the country of origin but unfamiliar in Indonesian population, and the presentation of racial tribes that do not describe variants of Indonesian racial tribes.

 

Conclusion: The WERF-EPHect Clinical Questionnaire (Standard) (EPQ-S) Indonesian version was obtained with contents according to the needs of users in Indonesia and can be applied at the RSCM, out of 116 questions there are 21 questions in the questionnaire that must be guided.

 

Keywords: Translation, Validation, WERF-EPHect Clinical Questionnaire (Standard), Clinical Phenotype, Endometriosis, Indonesia